CMBA
ALXN
C.M. Bidwell & Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-734
| Closed | -$135K | – | 639 |
|
|
2021
Q2 | $135K | Buy |
+734
| New | +$135K | 0.09% | 217 |
|
|
2020
Q1 | – | Sell |
-1,300
| Closed | -$141K | – | 493 |
|
|
2019
Q4 | $141K | Sell |
1,300
-1,980
| -60% | -$215K | 0.13% | 142 |
|
|
2019
Q3 | $321K | Buy |
3,280
+20
| +0.6% | +$1.96K | 0.32% | 91 |
|
|
2019
Q2 | $427K | Sell |
3,260
-3,570
| -52% | -$468K | 0.42% | 68 |
|
|
2019
Q1 | $923K | Buy |
6,830
+3,420
| +100% | +$462K | 0.92% | 15 |
|
|
2018
Q4 | $332K | Buy |
3,410
+3,160
| +1,264% | +$308K | 0.36% | 77 |
|
|
2018
Q3 | $35K | Hold |
250
| – | – | 0.03% | 256 |
|
|
2018
Q2 | $31K | Buy |
+250
| New | +$31K | 0.03% | 275 |
|